Lv6
3190 积分 2024-01-12 加入
Obesity, Underweight, and Accuracy of eGFR Using Cystatin C and Creatinine in a Northern European Population
5个月前
已完结
The body composition and excretory burden of lean, obese, and severely obese individuals has implications for the assessment of chronic kidney disease
5个月前
已完结
Obesity, Underweight, and Accuracy of eGFR Using Cystatin C and Creatinine in a Northern European Population
5个月前
已完结
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
5个月前
已完结
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial
5个月前
已完结
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
7个月前
已完结
GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist–Induced Nausea and Emesis in Preclinical Models
7个月前
已完结
Prevalence of obesity and associated complications in China: A cross‐sectional, real‐world study in 15.8 million adults
7个月前
已完结
Body-mass index and risk of obesity-related complex multimorbidity:an observational multicohort study
7个月前
已完结
Health policy and public health implications of obesity in China
7个月前
已完结
皖公网安备34019202002308
